RXRX Sep 2024 9.000 put
| Previous Close | 1.2500 |
| Open | 1.3900 |
| Bid | 1.4500 |
| Ask | 1.6500 |
| Strike | 9.00 |
| Expire Date | 2024-09-20 |
| Day's Range | 1.3900 - 1.5000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 581 |
GlobeNewswireRecursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,230 shares of its Class A common stock at a price to the public of $6.50 per share. All of the shares are to be sold by Recursion. In addition, Recursion has granted the underwriters a 30-day option to purchase up to an add
GlobeNewswireRecursion Announces Proposed Offering of Class A Common Stock
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that it intends to offer and sell $200.0 million of shares of its Class A common stock in an underwritten public offering. All of the shares of Class A common stock are being offered by Recursion. In addition, Recursion intends to grant to the underwriters a 30-day option to purch
ZacksRecursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing
Recursion Pharmaceuticals (RXRX) reachead $9.38 at the closing of the latest trading day, reflecting a +0.43% change compared to its last close.
